Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended June 30, 2026 and Declaration of Distributions on Common Stock for the Months Ending October
-
Hudbay Announces Correction to its Upcoming Dividend Record and Payment Dates
-
Castellum Schedules Second Quarter 2026 Earnings Release and Conference Call
-
Jushi Holdings Inc. Completes Redomicile from British Columbia to Nevada
-
Abercrombie & Fitch Co. to Report Second Quarter 2026 Results on August 26, 2026
-
Acorn – Provider of Monitoring and Control Solutions for Mission-Critical Assets Hosts Q2 Earnings Call Thursday Aug. 6th at 11am ET
-
J-Star Holding Co., Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
IES Holdings Reports Fiscal 2026 Third Quarter Results and Announces Two-for-One Stock Split
-
Notice on partial early redemption of bonds
-
YXT.com Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis
-
Dragonfly Energy Announces Strategic Acquisition of Dakota Lithium Assets, Expanding Into New Markets
-
Multilogin Repositions as a Cloud Phone Platform for Managing Multiple Social Media Accounts, Cuts Entry Price to $7.08/Month
-
Novo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation
-
Banco Itaú Chile Announces Second Quarter 2026 Management Commentary
-
DCX Announces Open-Market Share Purchase by Chief Executive Officer
-
IBN.Ai Launches Publicly Traded IBNAi Companion Coin / Token ($IBNAi)
-
IBN.Ai Launches Publicly Traded IBNAi Companion Coin / Token ($IBNAi)
-
Director/PDMR Shareholding
-
Transaction in Own Shares
-
TransAlta Reports Strong Second Quarter Results and Reaffirms Guidance
-
Ocugen to Participate in Upcoming August Investor Conferences
-
GCL Announces Fiscal Year 2026 Financial Results
-
George Weston Limited Reports Adjusted Diluted Net Earnings Per Common Share Growth of 12.9% in the Second Quarter
-
Radiopharm Theranostics Reports Business Update
-
The Orange Giant Announces ZHAI Has Entered Full Production
-
Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
-
Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
-
INmune Bio Receives R&D Rebates of Approximately $4.6 Million
-
Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab
-
Balchem Corporation Reports Second Quarter 2026 Financial Results
-
LEO Technologies Launches Verus ION, an Agentic AI-Powered Unified Intelligence and Investigative Solution for Corrections and Public Safety
-
Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation
-
INmune Bio Receives R&D Rebates of Approximately $4.6 Million
-
Green Thumb Expands Pennsylvania Retail Footprint with the Opening of RISE Dispensary Hanover
-
American Tungsten Corp. Begins Trading on OTCQX Best Market
-
INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th
-
Perella Weinberg Announces Partner Promotions
-
Perella Weinberg Reports Second Quarter 2026 Results
-
Brookfield Renewable Reports Strong Second Quarter Results
-
Bullish to announce second quarter 2026 financial results
-
Vireo Growth Inc. Announces a Four-Deal Transaction to Establish Presence in Ohio
-
Brookfield Business Corporation Reports Strong Second Quarter 2026 Results
-
Veridas Consolidated as a Visionary in the 2026 Gartner® Magic Quadrant™ for Identity Verification for Second Consecutive Year
-
nVent Electric plc Second Quarter 2026 Financial Results Available on Company’s Website
-
LyondellBasell reports second quarter 2026 earnings
-
Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2026 Financial Results
-
LAF Technology Launches RailFlex™ Railway Flexitank Series for Cross-Border Bulk Liquid Transportation
-
Italfarmaco Announces Managed Entry Agreement in Georgia for Givinostat as Treatment for Patients with Duchenne Muscular Dystrophy
-
FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM

